Health Care stocks
Tweenvest covers 5,282 listed health care companies. Each has a free page with its price history, key figures and factor scores.
| Company | Market cap | Price | Day |
|---|---|---|---|
| Genmab A/SCPSE: GMAB | $20.47B | Dkr2,196.00 | +3.98% |
| Torrent Pharmaceuticals LimitedBSE: 500420 | $19.40B | Rs4,880.50 | +0.83% |
| Viatris Inc.NasdaqGS: VTRS | $19.20B | $16.72 | +1.09% |
| Zimmer Biomet Holdings, Inc.NYSE: ZBH | $19.12B | $100.24 | -0.73% |
| PharmaEssentia CorporationTWSE: 6446 | $18.22B | NT$1,400.00 | -6.67% |
| Straumann Holding AGSWX: STMN | $18.18B | CHF91.54 | -1.46% |
| Sonova Holding AGSWX: SOON | $18.13B | CHF245.00 | +0.91% |
| IHH Healthcare BerhadKLSE: IHH | $18.12B | RM8.28 | +0.98% |
| Sartorius AktiengesellschaftXTRA: SRT3 | $17.80B | €246.50 | +1.40% |
| Sichuan Biokin Pharmaceutical Co.,Ltd.SHSE: 688506 | $17.36B | CN¥282.71 | -6.39% |
| Medpace Holdings, Inc.NasdaqGS: MEDP | $17.14B | $614.06 | -0.96% |
| Jazz Pharmaceuticals plcNasdaqGS: JAZZ | $16.89B | $260.23 | +2.26% |
| Swedish Orphan Biovitrum AB (publ)OM: SOBI | $16.87B | Skr469.60 | +2.09% |
| Ascendis Pharma A/SNasdaqGS: ASND | $16.61B | $252.99 | +0.41% |
| Coloplast A/SCPSE: COLO B | $16.29B | Dkr463.50 | +0.22% |
| ALTEOGEN Inc.KOSDAQ: A196170 | $16.08B | ₩320,000.00 | +1.91% |
| Ipsen S.A.ENXTPA: IPN | $15.88B | €166.00 | +2.09% |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.SEHK: 6990 | $15.85B | HK$520.50 | -3.52% |
| BridgeBio Pharma, Inc.NasdaqGS: BBIO | $15.72B | $80.40 | -0.83% |
| Solventum CorporationNYSE: SOLV | $15.59B | $91.61 | +0.39% |
| Neurocrine Biosciences, Inc.NasdaqGS: NBIX | $15.59B | $153.37 | +0.22% |
| Shionogi & Co., Ltd.TSE: 4507 | $15.55B | ¥2,911.00 | -0.36% |
| Rede D'Or São Luiz S.A.BOVESPA: RDOR3 | $15.27B | R$36.07 | +4.49% |
| Fisher & Paykel Healthcare Corporation LimitedNZSE: FPH | $15.27B | NZ$43.52 | +1.87% |
| Eurofins Scientific SEENXTPA: ERF | $15.01B | €74.08 | +1.12% |
| Olympus CorporationTSE: 7733 | $14.45B | ¥2,166.00 | +0.28% |
| Pro Medicus LimitedASX: PME | $14.25B | AU$190.60 | -1.46% |
| The Cooper Companies, Inc.NasdaqGS: COO | $14.25B | $73.04 | -3.64% |
| Charles River Laboratories International, Inc.NYSE: CRL | $14.21B | $297.64 | -0.31% |
| Exelixis, Inc.NasdaqGS: EXEL | $14.05B | $56.72 | +3.98% |
| Revvity, Inc.NYSE: RVTY | $13.93B | $124.84 | +1.50% |
| CSPC Pharmaceutical Group LimitedSEHK: 1093 | $13.73B | HK$9.41 | +0.16% |
| Baxter International Inc.NYSE: BAX | $13.59B | $26.29 | -0.76% |
| Corcept Therapeutics IncorporatedNasdaqCM: CORT | $13.36B | $123.57 | +0.27% |
| Orion OyjHLSE: ORNBV | $13.27B | €80.80 | +2.15% |
| Yunnan Baiyao Group Co.,LtdSZSE: 000538 | $13.09B | CN¥49.33 | -1.40% |
| Apollo Hospitals Enterprise LimitedNSEI: APOLLOHOSP | $13.06B | Rs8,693.00 | -2.55% |
| ICON Public Limited CompanyNasdaqGS: ICLR | $13.03B | $168.91 | -2.63% |
| Shanghai United Imaging Healthcare Co., Ltd.SHSE: 688271 | $12.89B | CN¥106.00 | -2.21% |
| BioMarin Pharmaceutical Inc.NasdaqGS: BMRN | $12.80B | $66.12 | +1.61% |
| Penumbra, Inc.NYSE: PEN | $12.78B | $324.37 | +0.19% |
| Sino Biopharmaceutical LimitedSEHK: 1177 | $12.76B | HK$5.62 | +0.63% |
| Recordati Industria Chimica e Farmaceutica S.p.A.BIT: REC | $12.60B | €52.70 | 0.00% |
| Arrowhead Pharmaceuticals, Inc.NasdaqGS: ARWR | $12.55B | $88.88 | +2.48% |
| Elanco Animal Health IncorporatedNYSE: ELAN | $12.54B | $25.09 | +2.74% |
| Fresenius Medical Care AGXTRA: FME | $12.48B | €40.36 | +0.15% |
| Halozyme Therapeutics, Inc.NasdaqGS: HALO | $12.41B | $109.32 | +0.63% |
| Tempus AI, Inc.NasdaqGS: TEM | $12.40B | $68.73 | +3.87% |
| Smith & Nephew plcLSE: SN. | $12.25B | £10.68 | -1.29% |
| Cipla LimitedNSEI: CIPLA | $12.09B | Rs1,432.20 | -1.23% |
| Pharmaron Beijing Co., Ltd.SZSE: 300759 | $12.06B | CN¥47.98 | -2.32% |
| BrightSpring Health Services, Inc.NasdaqGS: BTSG | $11.96B | $57.23 | -3.80% |
| Encompass Health CorporationNYSE: EHC | $11.85B | $120.14 | -0.65% |
| Madrigal Pharmaceuticals, Inc.NasdaqGS: MDGL | $11.83B | $512.16 | +0.04% |
| Aier Eye Hospital Group Co., Ltd.SZSE: 300015 | $11.73B | CN¥8.51 | +2.04% |
| Zydus Lifesciences LimitedNSEI: ZYDUSLIFE | $11.68B | Rs1,120.00 | -1.34% |
| Bio-Techne CorporationNasdaqGS: TECH | $11.34B | $72.33 | -0.08% |
| Align Technology, Inc.NasdaqGS: ALGN | $11.34B | $159.61 | -0.02% |
| DaVita Inc.NYSE: DVA | $11.34B | $177.80 | +0.74% |
| Globus Medical, Inc.NYSE: GMED | $11.14B | $82.96 | -1.33% |
| Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.SHSE: 600436 | $11.14B | CN¥124.10 | -6.40% |
| ABIVAX Société AnonymeENXTPA: ABVX | $11.12B | €101.80 | -1.45% |
| Haisco Pharmaceutical Group Co., Ltd.SZSE: 002653 | $10.98B | CN¥66.55 | -4.08% |
| Glaukos CorporationNYSE: GKOS | $10.90B | $181.39 | -1.89% |
| Cytokinetics, IncorporatedNasdaqGS: CYTK | $10.77B | $77.46 | +0.48% |
| Axsome Therapeutics, Inc.NasdaqGM: AXSM | $10.76B | $205.48 | +0.04% |
| Summit Therapeutics Inc.NasdaqGM: SMMT | $10.66B | $13.36 | +4.95% |
| Sichuan Kelun Pharmaceutical Co., Ltd.SZSE: 002422 | $10.62B | CN¥44.87 | -0.53% |
| Ionis Pharmaceuticals, Inc.NasdaqGS: IONS | $10.56B | $63.57 | +2.47% |
| Krystal Biotech, Inc.NasdaqGS: KRYS | $10.54B | $356.19 | +4.23% |
| Kymera Therapeutics, Inc.NasdaqGM: KYMR | $10.53B | $126.64 | +4.62% |
| Lupin LimitedBSE: 500257 | $10.48B | Rs2,193.00 | -1.88% |
| Mankind Pharma LimitedNSEI: MANKIND | $10.47B | Rs2,425.20 | -1.25% |
| Akeso, Inc.SEHK: 9926 | $10.45B | HK$88.90 | +0.62% |
| Dr. Reddy's Laboratories LimitedBSE: 500124 | $10.41B | Rs1,191.00 | -0.29% |
| Molina Healthcare, Inc.NYSE: MOH | $10.40B | $199.63 | +0.57% |
| bioMérieux S.A.ENXTPA: BIM | $10.37B | €75.50 | +1.55% |
| Universal Health Services, Inc.NYSE: UHS | $10.36B | $175.76 | -0.36% |
| The Ensign Group, Inc.NasdaqGS: ENSG | $10.35B | $179.02 | -0.20% |
| Bio-Rad Laboratories, Inc.NYSE: BIO | $10.31B | $390.34 | +2.25% |
| Praxis Precision Medicines, Inc.NasdaqGS: PRAX | $10.28B | $368.02 | -0.00% |
| Repligen CorporationNasdaqGS: RGEN | $10.25B | $181.69 | +0.04% |
| Laurus Labs LimitedNSEI: LAURUSLABS | $10.18B | Rs1,802.00 | +0.82% |
| Apogee Therapeutics, Inc.NasdaqGM: APGE | $10.17B | $134.85 | +0.04% |
| CSPC Innovation Pharmaceutical Co., Ltd.SZSE: 300765 | $10.15B | CN¥49.00 | +20.19% |
| Max Healthcare Institute LimitedBSE: 543220 | $10.14B | Rs997.00 | -1.29% |
| WuXi XDC Cayman Inc.SEHK: 2268 | $10.01B | HK$62.05 | -0.80% |
| Henry Schein, Inc.NasdaqGS: HSIC | $9.99B | $89.65 | +0.16% |
| Financière de Tubize SAENXTBR: TUB | $9.98B | €192.10 | +1.96% |
| Insulet CorporationNasdaqGS: PODD | $9.92B | $143.05 | -1.63% |
| PT Sejahteraraya Anugrahjaya TbkIDX: SRAJ | $9.78B | Rp14,100.00 | -6.00% |
| Avantor, Inc.NYSE: AVTR | $9.75B | $14.42 | +1.12% |
| Aurobindo Pharma LimitedNSEI: AUROPHARMA | $9.75B | Rs1,621.30 | -0.05% |
| Protagonist Therapeutics, Inc.NasdaqGM: PTGX | $9.74B | $150.59 | -2.67% |
| Manipal Health Enterprises LimitedNSEI: MANIPALHOS | $9.72B | Rs706.95 | +3.00% |
| Bangkok Dusit Medical Services Public Company LimitedSET: BDMS | $9.68B | ฿19.90 | +2.05% |
| Genscript Biotech CorporationSEHK: 1548 | $9.61B | HK$34.44 | +38.42% |
| Twist Bioscience CorporationNasdaqGS: TWST | $9.50B | $151.42 | +7.54% |
| Spyre Therapeutics, Inc.NasdaqGS: SYRE | $9.47B | $107.36 | +0.67% |
| Demant A/SCPSE: DEMANT | $9.37B | Dkr284.60 | -0.84% |